Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients
Molecular Therapy - Methods & Clinical Development · 2024-06 · 32 (2) · 101265
DOI: 10.1016/j.omtm.2024.101265 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy - Methods & Clinical Development, 2024-06. Verfasst von Tianjiao Wang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Biomarkers & Companion Diagnostics, Adaptimmune, Philadelphia, PA, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Biomarkers & Companion Diagnostics, Adaptimmune, Philadelphia, PA, USA.
- Biomarker Discovery and Platform, Adaptimmune, Philadelphia, PA, USA.
- Information Management Clinical Systems, Adaptimmune, Philadelphia, PA, USA.
- Assay Development Histopathology, CellCarta, Antwerpen, Belgium.
- Histopathology & Image Quantification Unit, CellCarta, Antwerpen, Belgium.
- Translational Sciences, Adaptimmune, Abingdon, Oxfordshire, UK.
Zitieren
APA
Wang, T., Navenot, J. M., Rafail, S., Kurtis, C., Carroll, M., Van Kerckhoven, M., Van Rossom, S., Schats, K., Avraam, K., Broad, R., Howe, K., Liddle, A., Clayton, A., Wang, R., Quinn, L., Sanderson, J. P., McAlpine, C., Carozza, C., Pimpinella, E., …, & Blumenschein, G. R. (2024). Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients. Molecular Therapy - Methods & Clinical Development, 32(2), 101265. https://doi.org/10.1016/j.omtm.2024.101265
Vancouver
Wang T, Navenot JM, Rafail S, Kurtis C, Carroll M, Van Kerckhoven M, et al. Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients. Molecular Therapy - Methods & Clinical Development. 2024;32(2):101265. doi:10.1016/j.omtm.2024.101265
BibTeX
@article{Wang2024,
author = {Wang, Tianjiao and Navenot, Jean-Marc and Rafail, Stavros and Kurtis, Cynthia and Carroll, Mark and Van Kerckhoven, Marian and Van Rossom, Sofie and Schats, Kelly and Avraam, Konstantinos and Broad, Robyn and Howe, Karen and Liddle, Ashley and Clayton, Amber and Wang, Ruoxi and Quinn, Laura and Sanderson, Joseph P and McAlpine, Cheryl and Carozza, Carly and Pimpinella, Eric and Hsu, Susan and Brophy, Francine and Elefant, Erica and Bayer, Paige and Williams, Dennis and Butler, Marcus O and Clarke, Jeffrey M and Gainor, Justin F and Govindan, Ramaswamy and Moreno, Victor and Johnson, Melissa and Tu, Janet and Hong, David S and Blumenschein, George R},
title = {Identifying MAGE-A4-positive tumors for TCR T cell therapies in HLA-A∗02-eligible patients},
journal = {Molecular Therapy - Methods & Clinical Development},
year = {2024},
volume = {32},
number = {2},
pages = {101265},
doi = {10.1016/j.omtm.2024.101265}
}
EUVIMED